BiotechTube
Home/Kala Pharmaceuticals/Kimberly M. Lee
KM

Kimberly M. Lee

Chief Corporate Strategy Officer and Head of Investor Relations

Kala Pharmaceuticals

Therapeutic Areas

OphthalmologyRare Diseases

Kala Pharmaceuticals Pipeline

DrugIndicationPhase
KPI-012Persistent Corneal Epithelial Defects (PCED)Phase 2b

Leadership Team at Kala Pharmaceuticals

MI
Mark Iwicki
Chairman, President and Chief Executive Officer
EL
Eric L. Trachtenberg
Chief Financial Officer
AR
Andrew R. Gow, Ph.D.
Chief Scientific Officer
MR
Mary Reumuth, J.D.
Chief Legal Officer and Corporate Secretary
MS
Marcio Souza
Board Director
RM
Rajeev M. Shah
Board Director
CY
Christopher Y. Chai
Board Director
View full Kala Pharmaceuticals profile